EXACT Therapeutics AS (DE:56F) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EXACT Therapeutics, a precision medicine company, has strengthened its board with the addition of Jonathan Allis and Flavien Daloz, both bringing extensive experience from the pharmaceutical and med-tech industries. This move aligns with the company’s strategy to advance its development pipeline and internationalize its operations, following a significant investment from GE Medical Holdings AB.
For further insights into DE:56F stock, check out TipRanks’ Stock Analysis page.